ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Tianyu Li
Matched on ORCID iD 0009-0005-0657-2768; OpenAlex author ID A5112233383. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2024: 3 papers · 2025: 4 papers · 2026: 1 paper
Papers 8
- IRP1/ARID3A complex promotes pancreatic cancer chemoresistance by suppressing CYGB-related ferroptosis. Co-author DOI 10.1016/j.gendis.2025.101866↗
- Nuclear localization of YAP in pancreatic cancer: More players besides Hippo pathway. Co-author DOI 10.1016/j.canlet.2025.217864↗
- Phthalocyanine and photodynamic therapy relieve albumin paclitaxel and gemcitabine chemoresistance in pancreatic cancer. Co-author DOI 10.1016/j.yexcr.2025.114455↗
- EDC4 enhances multi-drug chemosensitivity in pancreatic cancer via GR50-based profiling. First author DOI 10.1186/s12935-025-04000-9↗
- Extracellular vesicles-miR-205-5p inhibits lymphatic metastasis in pancreatic cancer through diffusely downregulating VEGFA. Co-author DOI 10.7150/jca.110659↗
- Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets. Co-author DOI 10.1016/j.bbcan.2024.189183↗
- Circulating tumor cells in pancreatic cancer: more than liquid biopsy. Co-author DOI 10.1177/17588359241284935↗
- Construction of a prognostic model with exosome biogenesis- and release-related genes and identification of RAB27B in immune infiltration of pancreatic cancer. Co-author DOI 10.21037/tcr-24-54↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bangbo Zhao · 8 shared papers, 2024–2026 · strength 1.99
- Paper IRP1/ARID3A complex promotes pancreatic cancer chemoresistance by suppressing CYGB-related ferroptosis. DOI 10.1016/j.gendis.2025.101866↗
- Paper Phthalocyanine and photodynamic therapy relieve albumin paclitaxel and gemcitabine chemoresistance in pancreatic cancer. DOI 10.1016/j.yexcr.2025.114455↗
- Paper Extracellular vesicles-miR-205-5p inhibits lymphatic metastasis in pancreatic cancer through diffusely downregulating V… DOI 10.7150/jca.110659↗
- Zeru Li · 8 shared papers, 2024–2026 · strength 1.99
- Paper IRP1/ARID3A complex promotes pancreatic cancer chemoresistance by suppressing CYGB-related ferroptosis. DOI 10.1016/j.gendis.2025.101866↗
- Paper Phthalocyanine and photodynamic therapy relieve albumin paclitaxel and gemcitabine chemoresistance in pancreatic cancer. DOI 10.1016/j.yexcr.2025.114455↗
- Paper Extracellular vesicles-miR-205-5p inhibits lymphatic metastasis in pancreatic cancer through diffusely downregulating V… DOI 10.7150/jca.110659↗
- Yutong Zhao · 7 shared papers, 2024–2026 · strength 1.75
- Paper IRP1/ARID3A complex promotes pancreatic cancer chemoresistance by suppressing CYGB-related ferroptosis. DOI 10.1016/j.gendis.2025.101866↗
- Paper Phthalocyanine and photodynamic therapy relieve albumin paclitaxel and gemcitabine chemoresistance in pancreatic cancer. DOI 10.1016/j.yexcr.2025.114455↗
- Paper Extracellular vesicles-miR-205-5p inhibits lymphatic metastasis in pancreatic cancer through diffusely downregulating V… DOI 10.7150/jca.110659↗
- Cheng Yong Qin · 6 shared papers, 2024–2026 · strength 1.52
- Paper IRP1/ARID3A complex promotes pancreatic cancer chemoresistance by suppressing CYGB-related ferroptosis. DOI 10.1016/j.gendis.2025.101866↗
- Paper Phthalocyanine and photodynamic therapy relieve albumin paclitaxel and gemcitabine chemoresistance in pancreatic cancer. DOI 10.1016/j.yexcr.2025.114455↗
- Paper Extracellular vesicles-miR-205-5p inhibits lymphatic metastasis in pancreatic cancer through diffusely downregulating V… DOI 10.7150/jca.110659↗
- Weibin Wang · 4 shared papers, 2024–2025 · strength 1.02
- Paper Phthalocyanine and photodynamic therapy relieve albumin paclitaxel and gemcitabine chemoresistance in pancreatic cancer. DOI 10.1016/j.yexcr.2025.114455↗
- Paper Extracellular vesicles-miR-205-5p inhibits lymphatic metastasis in pancreatic cancer through diffusely downregulating V… DOI 10.7150/jca.110659↗
- Paper Circulating tumor cells in pancreatic cancer: more than liquid biopsy. DOI 10.1177/17588359241284935↗
- Weibin Wang · 4 shared papers, 2024–2026 · strength 0.97
- Paper IRP1/ARID3A complex promotes pancreatic cancer chemoresistance by suppressing CYGB-related ferroptosis. DOI 10.1016/j.gendis.2025.101866↗
- Paper Nuclear localization of YAP in pancreatic cancer: More players besides Hippo pathway. DOI 10.1016/j.canlet.2025.217864↗
- Paper EDC4 enhances multi-drug chemosensitivity in pancreatic cancer via GR50-based profiling. DOI 10.1186/s12935-025-04000-9↗
- Yiping Xie · 3 shared papers, 2025–2026 · strength 0.75
- Paper IRP1/ARID3A complex promotes pancreatic cancer chemoresistance by suppressing CYGB-related ferroptosis. DOI 10.1016/j.gendis.2025.101866↗
- Paper Nuclear localization of YAP in pancreatic cancer: More players besides Hippo pathway. DOI 10.1016/j.canlet.2025.217864↗
- Paper EDC4 enhances multi-drug chemosensitivity in pancreatic cancer via GR50-based profiling. DOI 10.1186/s12935-025-04000-9↗
- Haoyu Shi · 2 shared papers, 2025–2026 · strength 0.52
- Yuanyang Wang · 1 shared paper, 2025 · strength 0.27
- Cheng‐Feng Qin · 1 shared paper, 2024 · strength 0.24
- Yuanyang Wang · 1 shared paper, 2024 · strength 0.24
- Cheng Qin · 1 shared paper, 2024 · strength 0.23
- Lin Chen · 1 shared paper, 2024 · strength 0.23
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.